Skip to main content

Trustwise

AI Security, AI Trust Management, Compliance Solutions

Research Paper

Risks Associated With The Use Of Information Technologies Include Which Of The Following in Pharmaceuticals | Compliance

AI Trust Management for Pharmaceuticals: Ensure Information Technology Security Now. Pharmaceuticals Guide to Risks Associated With The Use Of Information Technologies Include Which Of The Following.
Background Heroefooter
AI Compliance

AI Security and Compliance in Pharmaceuticals

Trustwise delivers an AI Security and Control Layer, which includes AI Trust Management for Agentic AI Systems. Modern AI projects fail to scale, not because of a lack of ambition, but due to unreliability, inefficiency, and lack of control. This is the Trust Gap, a critical barrier to achieving widespread AI adoption. The emergence of agentic AI only widens this gap, introducing greater complexity and risk. Our solutions (Harmony Ai) minimize the Trust Gap throughout the entire AI lifecycle, from simulation and verification to optimization and governance. Trustwise helps large organizations realize AI Trust and Security at scale.

Risks in Information Technologies

The use of information technologies brings significant risks that must be carefully managed. As the Head of Compliance at a large Pharmaceuticals company, it is crucial to be aware of potential threats associated with information technologies. Below are some of the key risks to consider:

– Cybersecurity Threats:

– With the increasing reliance on digital platforms and data storage, pharmaceutical companies are vulnerable to cyber attacks. This includes potential breaches of sensitive patient data, intellectual property theft, and disruption of critical operations.

– Compliance and Regulatory Risks:

– The pharmaceutical industry is heavily regulated, and the use of information technologies brings compliance challenges. Failure to adhere to industry standards and regulations can result in severe penalties and reputational damage.

– Data Privacy Concerns:

– Protecting the privacy of patients’ and employees’ data is paramount. Information technologies create opportunities for unauthorized access, data leaks, and privacy breaches, which can lead to legal liabilities and loss of trust.

– Integration and Interoperability Risks:

– In multi-cloud or partner-integrated environments, the integration of diverse information technologies can lead to compatibility issues, data inconsistencies, and operational disruptions.

– Emerging Technology Vulnerabilities:

– The rapid evolution of technology introduces new vulnerabilities and risks. Managing the security and trustworthiness of AI systems, IoT devices, and other emerging technologies is essential to mitigate potential threats.

Mitigating Risks with Trustwise’s Solutions

Trustwise offers comprehensive solutions to address the risks associated with information technologies, particularly for pharmaceutical companies. Our approach focuses on embedding real-time security, control, and alignment into every agent, ensuring that innovation scales without compromising control. Here’s how our solutions can mitigate these risks:

– Cybersecurity Enhancement:

– Trustwise’s AI Security and Control Layer provides real-time threat detection and mitigation, safeguarding pharmaceutical companies from cyber attacks and unauthorized access.

– Compliance and Regulatory Support:

– Our solutions include AI Trust Management, ensuring compliance with industry regulations and standards throughout the AI lifecycle, minimizing the risk of non-compliance and associated penalties.

– Data Privacy Assurance:

– With trust-as-code delivered through APIs, SDKs, MCPs, and Guardian Agents, Trustwise ensures that data privacy is prioritized and protected in every aspect of pharmaceutical operations.

– Integration and Interoperability Optimization:

– Trustwise’s solutions facilitate seamless integration and interoperability in multi-cloud and partner-integrated environments, reducing the risk of compatibility issues and operational disruptions.

– Vulnerability Management for Emerging Technologies:

– Harmony Ai minimizes the Trust Gap for emerging technologies, providing pharmaceutical companies with the assurance of secure and reliable AI systems and IoT devices.

Schedule Demo

To gain deeper insights into how Trustwise’s solutions can address the risks associated with information technologies in the pharmaceutical industry, schedule a demo with our team today. Experience firsthand how our AI Security and Control Layer, powered by AI Trust Management, can provide your organization with the visibility and control needed to mitigate potential threats and achieve AI Trust and Security at scale.

About Trustwise

Trustwise provides AI Trust Management that enables enterprises to deploy safe, compliant and efficient AI at scale. The company’s platform serves as the AI Control Tower for agentic AI, providing real-time governance and control through Guardian Agents and modular AI Shields. Co-developed with leading financial and healthcare institutions, Trustwise helps Global 500 enterprises keep AI trustworthy and aligned at runtime in high-stakes environments. The company was named a Cool Vendor in the 2025 Gartner® Cool Vendors™ for Agentic AI in Banking and Investment Services report and received the InfoWorld 2024 Technology of the Year Award.

Frame 2085665762

Resources

Frame 2085665762 (1)

Media Contact

Bhava Communications for Trustwise

trustwise@bhavacom.com

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and COOL VENDORS is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation.

Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Related topics

Untitled design (9)

July 9, 2026

Stop Governing AI, Start Controlling It

There's a phrase burned into the brain of every security professional who's been doing this long enough: compliance does not equal security. In other words, you can’t be secure through documentation. We’ve learned that lesson the hard way, consistently watching organizations pass compliance reviews while still getting breached. A perfectly completed questionnaire has never stopped a ransomware attack. A SOC 2 report has never blocked a credential stuffing campaign. Documentation describes a security posture. It doesn't create one.

Trustwise

July 9, 2026

Trustwise Blog Post Graphics (1)

July 8, 2026

A Breakthrough Year for Enterprise AI, and Why Trust Matters More Than Ever

In 2025, something remarkable happened in the world of enterprise AI: many organizations went from simply experimenting with AI to entrusting it with a portion of their real business outcomes. The success of that shift from curiosity to operational reliance continues to hinge on the realization that AI capability without trust creates risk.

Trustwise

July 8, 2026

Trustwise Top 5 Reasons Agentic AI Can Be Unsafe Blog cover

July 7, 2026

Why Agentic AI Isn’t Always Safe And How Trustwise Fixes It at Runtime

Agentic AI isn’t on the horizon; it’s already inside enterprise systems, making autonomous decisions, triggering real-world actions, and interacting with sensitive data in real time.

Trustwise

July 7, 2026

Stay informed

Get our latest insights
and articles
in your inbox.

Field signal from the front lines of enterprise AI research,
perspectives, and product news from the team building runtime control.

Background Heroefooter